KR870000497B1 - N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법 - Google Patents

N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법 Download PDF

Info

Publication number
KR870000497B1
KR870000497B1 KR1019850003013A KR850003013A KR870000497B1 KR 870000497 B1 KR870000497 B1 KR 870000497B1 KR 1019850003013 A KR1019850003013 A KR 1019850003013A KR 850003013 A KR850003013 A KR 850003013A KR 870000497 B1 KR870000497 B1 KR 870000497B1
Authority
KR
South Korea
Prior art keywords
carbon atoms
alkyl
oxyindole
formula
chloro
Prior art date
Application number
KR1019850003013A
Other languages
English (en)
Korean (ko)
Other versions
KR850008154A (ko
Inventor
베르나르드 카딘 사울
Original Assignee
화이자 인코퍼레이티드
윌리암 데이비스 휸
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코퍼레이티드, 윌리암 데이비스 휸 filed Critical 화이자 인코퍼레이티드
Publication of KR850008154A publication Critical patent/KR850008154A/ko
Application granted granted Critical
Publication of KR870000497B1 publication Critical patent/KR870000497B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019850003013A 1984-05-04 1985-05-03 N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법 KR870000497B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04
US607,356 1984-05-04

Publications (2)

Publication Number Publication Date
KR850008154A KR850008154A (ko) 1985-12-13
KR870000497B1 true KR870000497B1 (ko) 1987-03-12

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850003013A KR870000497B1 (ko) 1984-05-04 1985-05-03 N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법

Country Status (25)

Country Link
JP (1) JPS60243068A (ro)
KR (1) KR870000497B1 (ro)
AR (1) AR241159A1 (ro)
BG (2) BG60208B2 (ro)
CS (1) CS252828B2 (ro)
DD (1) DD232916A5 (ro)
EG (1) EG17193A (ro)
ES (2) ES8609248A1 (ro)
FI (1) FI80016C (ro)
HU (1) HU196057B (ro)
IE (1) IE851103L (ro)
IN (1) IN161509B (ro)
MA (1) MA20424A1 (ro)
MW (1) MW1685A1 (ro)
MX (1) MX5839A (ro)
NO (1) NO163132C (ro)
OA (1) OA08098A (ro)
PL (2) PL145416B1 (ro)
PT (1) PT80375B (ro)
RO (2) RO94455B (ro)
RU (1) RU2017729C1 (ro)
SU (1) SU1468413A3 (ro)
YU (1) YU44998B (ro)
ZA (1) ZA853324B (ro)
ZW (1) ZW7885A1 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
RO94455B (ro) 1988-07-01
HUT37754A (en) 1986-02-28
MW1685A1 (en) 1986-09-10
CS252828B2 (en) 1987-10-15
YU73085A (en) 1988-04-30
FI80016C (fi) 1990-04-10
PL145416B1 (en) 1988-09-30
PL257892A1 (en) 1986-10-07
BG60208B2 (en) 1993-12-30
IN161509B (ro) 1987-12-19
RO94455A (ro) 1988-06-30
FI851756L (fi) 1985-11-05
ES8609248A1 (es) 1986-07-16
YU44998B (en) 1991-06-30
AR241159A1 (es) 1991-12-30
ZA853324B (en) 1986-12-30
CS320285A2 (en) 1987-03-12
NO163132C (no) 1990-04-11
PT80375A (en) 1985-05-01
KR850008154A (ko) 1985-12-13
JPH0335315B2 (ro) 1991-05-27
PL147508B1 (en) 1989-06-30
MX5839A (es) 1993-11-01
AR241159A2 (es) 1991-12-30
ZW7885A1 (en) 1985-07-24
HU196057B (en) 1988-09-28
RO91141A (ro) 1987-06-30
JPS60243068A (ja) 1985-12-03
DD232916A5 (de) 1986-02-12
RO91141B (ro) 1987-07-03
RU2017729C1 (ru) 1994-08-15
EG17193A (en) 1990-08-30
NO851774L (no) 1985-11-05
MA20424A1 (fr) 1985-12-31
FI80016B (fi) 1989-12-29
ES551275A0 (es) 1987-07-16
BG60207B2 (en) 1993-12-30
OA08098A (fr) 1987-03-31
PL253203A1 (en) 1986-06-17
IE851103L (en) 1985-11-04
ES542813A0 (es) 1986-07-16
FI851756A0 (fi) 1985-05-03
PT80375B (pt) 1987-09-30
NO163132B (no) 1990-01-02
SU1468413A3 (ru) 1989-03-23
ES8707182A1 (es) 1987-07-16

Similar Documents

Publication Publication Date Title
KR860001873B1 (ko) 3-치환된 2-옥신돌-1-카르복스아미드의 제조방법
US4690943A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
EP0164860B1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
KR880000434B1 (ko) 3-치환된 옥스인돌 화합물 및 그의 제조방법
AU2782599A (en) Inhibitors of phospholipase enzymes
KR860001874B1 (ko) 2-옥스인돌-1-카복스 아미드의 제조방법
KR870000497B1 (ko) N, 3-이치환된 2-옥시인돌-1-카복사마이드의 제조방법
EP0153818A2 (en) 1,3-Disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
JP2709530B2 (ja) 抗炎症薬としてのオキシンドール1−[n−(アルコキシカルボニル)]カルボキサミド類および1−(n−カルボキサミド)カルボキサミド類
KR870000289B1 (ko) 2-옥스인돌 유도체의 제조방법
US4808601A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
FR2663634A1 (fr) Nouvelles acyl benzoxazolinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US4665194A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
JPS60209564A (ja) 鎮痛性抗炎症剤として有効な、2‐オキシインドール‐1‐カルボキサミド化合物
US4652658A (en) Process for making 2-oxindole-1-carboxamides and intermediates therefor
EP0365416B1 (fr) Nouveaux dérivés de l'amino chromanol, leur procédé de préparation et les compositions pharmaceutiques les renfermant
CA1289556C (en) 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents
HU193942B (en) Process for preparing 1,3-disubstituted 2-oxindole derivatives

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050203

Year of fee payment: 19

EXPY Expiration of term